Yeonhee Park to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Yeonhee Park has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.171
-
Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.
Score: 0.130
-
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study. Am J Hematol. 2023 02; 98(2):300-308.
Score: 0.040